Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates

scientific article published in December 1992

Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.12.12.1503
P698PubMed publication ID1450182

P2093author name stringM Hermann
B Gmeiner
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)1503-6
P577publication date1992-12-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleAltered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates
P478volume12

Reverse relations

cites work (P2860)
Q42411907Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion
Q77653303Aggregation of LDL with chondroitin-4-sulfate makes LDL oxidizable in the presence of water-soluble antioxidants
Q43833309Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids
Q41432893Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
Q44219160Homocysteine promotes the LDL oxidase activity of ceruloplasmin
Q78044117Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis
Q73110368Oxidation of heparin-treated low density lipoprotein by peroxidases
Q61978284Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals
Q61978281Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid
Q46678821The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.
Q61978280The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein
Q61978290Tyrosine: an inhibitor of LDL oxidation and endothelial cell cytotoxicity initiated by superoxide/nitric oxide radicals 1
Q31924329p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.

Search more.